Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study

BACKGROUND AND AIMS: Thrombosis is a major driver of adverse outcome and mortality in patients with Coronavirus disease 2019 (COVID-19). Hypercoagulability may be related to the cytokine storm associated with COVID-19, which is mainly driven by interleukin (IL)-6. Plasma lipoprotein(a) [Lp(a)] level...

Descripción completa

Detalles Bibliográficos
Autores principales: Nurmohamed, Nick S., Collard, Didier, Reeskamp, Laurens F., Kaiser, Yannick, Kroon, Jeffrey, Tromp, Tycho R., van den Born, Bert-Jan H., Coppens, Michiel, Vlaar, Alexander P.J., Beudel, Martijn, van de Beek, Diederik, van Es, Nick, Moriarty, Patrick M., Tsimikas, Sotirios, Stroes, Erik S.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690577/
https://www.ncbi.nlm.nih.gov/pubmed/34995986
http://dx.doi.org/10.1016/j.atherosclerosis.2021.12.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690577/
https://www.ncbi.nlm.nih.gov/pubmed/34995986
http://dx.doi.org/10.1016/j.atherosclerosis.2021.12.008

Ejemplares similares